← Back to Search

ACE4 and TAU for Anxiety and Depression

N/A
Waitlist Available
Led By Farooq Naeem, MsC, PhD
Research Sponsored by Queen's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the base line and then at the end of therapy (8 weeks).
Awards & highlights

Study Summary

Behavioral activation (BA) is a low cost, evidence-based intervention that can be effective in treating depression and anxiety. We have developed a behavioural activation card game for clients receiving treatment through the Crisis Team and Traditional Case Management (TCM) in Kingston, ON. The game is designed to integrate behavioural activation tools into daily life while receiving points for completion of the each Activity Challenge, which are divided into 4 areas (ACE4), with the goal to receive maximum amount of points in the timeframe of the study. Using a Randomized Control Trial (RCT) design, participants (n=40) will be assigned to one of two groups, with the intervention group receiving ACE4 and treatment as usual (TAU) and the control group only receiving TAU. Assessments will be carried out upon entry to the study and at the end of the intervention period (8 weeks). Assessments will be completed using the WHODAS 2.0 (World Health Organization Disability Assessment Schedule), HADS (The Hospital Anxiety and Depression Scale), and CORE (Clinical Outcome in Routine Evaluation). We hypothesize that the treatment group receiving the ACE4 intervention will show improvement in overall mental state. Analyses will be conducted using SPSSv16, an analysis of covariance and t-test, and a binary logistic regression analysis will be used to investigate factors that predict good outcomes. Results will be published in international journals and presented at conferences with an aim towards being applied to clinics in Pakistan.

Eligible Conditions
  • Anxiety and Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the base line and then at the end of therapy (8 weeks).
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the base line and then at the end of therapy (8 weeks). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The Hospital Anxiety and Depression Scale (HAD)
Secondary outcome measures
Brief Disability Questionnaire (BDQ)
The Clinical Outcome in Routine Evaluation (CORE)

Trial Design

2Treatment groups
Active Control
Group I: TAU OnlyActive Control1 Intervention
This group will receive only the treatment as usual.
Group II: ACE4 and TAUActive Control1 Intervention
This group will receive ACE4 as an intervention and treatment as usual.

Find a Location

Who is running the clinical trial?

Queen's UniversityLead Sponsor
365 Previous Clinical Trials
120,297 Total Patients Enrolled
Farooq Naeem, MsC, PhDPrincipal InvestigatorQueen's University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~12 spots leftby Apr 2025